Ionotropic cross-linking of biopolymers : applications in drug delivery /

Ionotropic Cross-Linking of Biopolymers: Applications in Drug Delivery provides in-depth insights and presents the latest advances in ionotropic cross-linked biopolymeric systems for drug delivery and related applications.

Bibliographic Details
Corporate Author: ScienceDirect (Online service)
Other Authors: Nayak, Amit Kumar, 1979-, Hasnain, Md Saquib, 1984-
Format: eBook
Language:English
Published: Amsterdam : Elsevier, 2024.
Subjects:
Online Access:Connect to the full text of this electronic book
Table of Contents:
  • Front Cover
  • Ionotropic Cross-Linking of Biopolymers
  • Copyright Page
  • Contents
  • List of contributors
  • 1 Introduction and fundamentals
  • 1 Ionotropic cross-linking of biopolymers: basics and mechanisms
  • 1.1 Introduction
  • 1.2 Ionotropic gelation technique
  • 1.3 Counter-ions (ionic cross-linkers) for ionotropic gelation
  • 1.4 Some common ionic biopolymers and their ionotropic gelations
  • 1.4.1 Alginates
  • 1.4.2 Pectins
  • 1.4.3 Gellan gum
  • 1.4.4 Chitosan
  • 1.4.5 Carrageenan
  • 1.4.6 Dextran
  • 1.4.7 Carboxymethyl polysaccharides
  • 1.5 Formation of polyelectrolyte complexes via ionotropic gelations
  • 1.6 Ionotropically gelled biopolymeric systems in drug delivery
  • 1.7 Conclusion
  • References
  • 2 Fundamentals and applications of ionic biopolymers
  • 2.1 Introduction
  • 2.2 Properties and advantages of ionic biopolymers
  • 2.3 Challenges and limitations of ionic biopolymers
  • 2.4 Preparation of Ionic Biopolymers
  • 2.4.1 Polysaccharide/polysaccharide blends
  • 2.4.2 Polysaccharide/polypeptide blends
  • 2.4.3 Polysaccharide/bioplastic blends
  • 2.5 Incorporation of pharmaceutical ingredients into biopolymer-based drug-delivery systems using ionic liquids
  • 2.6 Strategies for assimilating pharmaceutical ingredients into biopolymer-based drug-delivery systems using ionic liquids
  • 2.7 Electrospinning of biopolymer composites using ionic liquids
  • 2.8 Enzyme-catalyzed processes in ionic liquids for biopolymer modification
  • References
  • 3 Ionotropic cross-linking methods for different types of biopolymeric hydrogels
  • 3.1 Introduction
  • 3.2 Preparation of hydrogels
  • 3.2.1 Chemical gelation
  • 3.2.2 Physical gelation
  • 3.2.2.1 Ionotropic gelation
  • 3.2.2.2 Chitosan ionic gelation
  • 3.2.2.2.1 Alginate gelation
  • 3.2.2.2.2 Pectin
  • 3.2.2.2.3 Biomedical application
  • 3.3 Conclusion
  • References.
  • 4 Ionotropic gelation in advanced drug delivery
  • 4.1 Introduction
  • 4.2 Biopolysaccharides
  • 4.2.1 Definition
  • 4.2.2 Properties
  • 4.2.3 Composition
  • 4.2.4 Classifications
  • 4.2.4.1 By structure
  • 4.2.4.1.1 Homopolysaccharides
  • 4.2.4.1.2 Heteropolysaccharides
  • 4.2.4.2 By source
  • 4.2.4.3 By functions
  • 4.3 Industrial applications of biopolysaccharides
  • 4.4 Biomaterials-based hydrogels
  • 4.4.1 Definition of hydrogel
  • 4.4.2 Preparation techniques of hydrogels
  • 4.4.3 Advantages of hydrogels
  • 4.4.4 Hydrogels applications
  • 4.5 Hydrogels based on biopolysaccharides and its potential application in drugs delivery
  • 4.6 Conclusion
  • References
  • 2 Ionotropically cross-linked biopolymers
  • 5 Utilizing alginate-based delivery systems for anticancer therapeutics
  • 5.1 Introduction
  • 5.2 Alginate delivery systems
  • 5.2.1 Alginate delivery systems used against colon cancer
  • 5.2.2 Alginate delivery systems against breast and hepatic cancer
  • 5.2.3 Alginate delivery systems used in various cell lines
  • 5.3 Conclusion
  • References
  • 6 Ionotropically crosslinked pectinate-based systems for drug delivery
  • 6.1 Introduction
  • 6.2 Pectin
  • 6.2.1 Occurrence and structure
  • 6.2.2 Physical and chemical behavior
  • 6.2.3 Crosslinking of pectin
  • 6.2.4 Factors affecting crosslinking
  • 6.2.5 Types of crosslinking
  • 6.2.5.1 Physical crosslinking
  • 6.2.5.2 Chemical crosslinking
  • 6.2.5.3 Ionotropic crosslinking
  • 6.2.5.4 Miscellaneous crosslinking
  • 6.2.6 Properties of crosslinked pectin (pectinate)
  • 6.3 Applications of pectinate in drug delivery systems
  • 6.3.1 pH-responsive drug delivery systems
  • 6.3.2 Colon-specific targeting drug delivery systems
  • 6.3.3 Floating drug delivery systems
  • 6.3.4 Pulsatile drug delivery systems
  • 6.3.5 Miscellaneous drug delivery systems
  • 6.4 Current challenges and future prospects.
  • 9.8.2 Swelling and charge density
  • 9.8.3 Ionic cross-linkers
  • 9.9 Ionotropical cross-linked carboxymethylated gums-based systems in drug delivery
  • 9.9.1 Carboxymethylated xanthan gum
  • 9.9.2 Carboxymethylated guar gum
  • 9.9.3 Miscellaneous
  • 9.10 Conclusion
  • References
  • 10 Starches-blended ionotropically cross-linked biopolymeric matrices for sustained drug release
  • 10.1 Introduction
  • 10.1.1 Overview on starch
  • 10.2 Ionotropic gelation of starch
  • 10.3 Drug delivery applications
  • 10.3.1 Rice starch
  • 10.3.2 Jackfruit seed starch
  • 10.3.3 Potato starch
  • 10.3.4 Arrowroot
  • 10.3.5 Cassava starch
  • 10.3.6 Other starch
  • 10.3.7 Modified starch
  • 10.4 Other applications
  • 10.5 Future remarks and conclusions
  • Acknowledgments
  • References
  • 3 Ionotropically cross-linked biopolymeric systems
  • 11 Ionotropically cross-linked polymeric nanoparticles for drug delivery
  • 11.1 Introduction
  • 11.2 Cross-linking technique for polymeric nanodrug delivery systems
  • 11.2.1 Types of cross-linking technique
  • 11.2.2 Hydrogel as cross-linked polymer
  • 11.2.3 The importance of cross-linked polymeric nanoparticles for drug delivery
  • 11.3 Ionotropic cross-linking technique
  • 11.3.1 The mechanism of ionotropic cross-linking technique
  • 11.3.2 Factors affecting preparation of ionotropically cross-linked polymeric nanoparticles
  • 11.3.2.1 Effect of concentration
  • 11.3.2.2 Effect of polyanion
  • 11.3.2.3 Effect of surfactant
  • 11.3.2.4 Effect of sonication
  • 11.3.2.5 Temperature
  • 11.3.2.6 pH of cross-linking solution
  • 11.3.3 Ionotropic cross-linked polymeric nanoparticles
  • 11.3.3.1 Chitosan
  • 11.3.3.2 Alginate
  • 11.3.3.3 Other polymeric species
  • 11.4 Applications
  • 11.5 Conclusion
  • References
  • 12 Ionotropically cross-linked polymeric microparticles for drug delivery
  • 12.1 Introduction.
  • 12.2 Polymers in ionotropic gelation for drug delivery
  • 12.2.1 Chitosan
  • 12.2.2 Alginate
  • 12.3 Methods of ionotropic gelation
  • 12.4 Specific drug delivery applications of ionotropic-gelated microparticles
  • 12.4.1 Controlled drug delivery
  • 12.4.2 Targeted drug delivery
  • 12.4.3 Vaccine delivery
  • 12.4.4 Bioactive phytochemical compounds from plant
  • 12.4.5 Encapsulation of probiotics
  • 12.5 Evaluation of microparticles prepared by ionotropic gelation
  • 12.5.1 Polymer-drug compatibility
  • 12.5.1.1 Fourier transform infrared
  • 12.5.1.2 Thermoanalytical methods
  • 12.5.1.3 X-ray diffraction spectroscopy
  • 12.5.2 Morphology
  • 12.5.3 Zeta potential analysis
  • 12.5.4 Porosity and density
  • 12.5.5 Flow properties and compressibility index
  • 12.5.6 Swelling index and erosion
  • 12.5.7 Drug entrapment efficiency
  • 12.5.8 Drug release study
  • 12.5.8.1 Using dissolution test apparatus
  • 12.5.8.2 Using container
  • 12.5.8.3 Dialysis membrane method
  • 12.5.9 Release mechanism
  • 12.5.10 Mechanical strength of microparticles
  • 12.6 Conclusion
  • Conflict of interest
  • References
  • 13 Ionotropic cross-linked polymeric beads for drug delivery and in vitro applications
  • 13.1 Introduction
  • 13.2 Ionotropic polymers: basic mechanisms and processing techniques
  • 13.2.1 Dripping method
  • 13.2.2 Vibrating nozzle or laminar jet breakup
  • 13.2.3 Mechanical cutting or jet cutter technology
  • 13.2.4 Electrohydrodynamic atomization
  • 13.3 Classification of ionotropic biopolymers
  • 13.3.1 Alginate
  • 13.3.2 Chitosan
  • 13.3.3 Carboxymethyl cellulose
  • 13.3.4 Gellan gum
  • 13.4 Applications
  • 13.4.1 Drug delivery
  • 13.4.2 In vitro applications
  • Acknowledgments
  • References
  • 14 Clay-reinforced ionotropically cross-linked biopolymeric matrices for drug release
  • 14.1 Introduction.